Thermo Fisher Scientific™ is at the forefront of the global response to coronavirus, working with; governments, agencies, industry partners and researchers globally, to ensure priority access to instruments, consumables, safety supplies and other products to address the outbreak.
Clinical microbiology laboratories have seen an influx of additional tests to identify viral and bacterial infections presenting similar symptoms to coronavirus. Identification of coronavirus as well as similar or related infections is vital to rapidly address the outbreak.
Within Clinical Microbiology we have focused on increasing our manufacturing capacity to deliver viral collection kits and transport media globally. As well as continuing to supply our microbial isolation and identification products and our Antimicrobial Susceptibility Testing (AST) range to maintain antibiotic stewardship even when faced with a pandemic.
Explore the Thermo Scientific™ coronavirus care product mix, from viral and bacterial identification to quality control organisms.
Rule in/out the presence of viral infections which may present similar symptoms to Coronavirus
Product Code | Product name | Usage |
Collection and transport | ||
| R12587 | M4RT (3ml) Tube | Viruses, chlamydiae |
| R12588 | M4RT (3ml) Flock Swab Kit | Viruses, chlamydiae |
| R12700 | M4RT (3ml) w/o Beads Tube | Viruses, chlamydiae |
| R12705 | M4RT (3ml) w/o Beads NP Swab Kit | Viruses, chlamydiae |
Detectand isolate | ||
Xpect™ Flu A & B Test | Influenza A and Influenza B viral antigens | |
Xpect™ RSV Test | Respiratory Syncytial Virus | |
Remel™ Xpect™ Flu A and B Control Swab | Flu A & B Control Swabs | |
Remel™ Xpect™ RSV Control Kit | RSV Control Kit | |
Remel™ PathoDx™ Respiratory Virus Panel | Influenza A; influenza B; .Adenovirus, Parainfluenza 1, 2 and 3, Respiratory Syncytial Virus (RSV) | |
Please contact your Microbiology account manager for product availability
Address an increase in patients with ventilator-associated pneumonia (HAP/VAP), or bacterial respiratory co-infections which can prolong the duration of ventilator use and length of stay.
Product Code | Product name | Usage |
Collection and transport | ||
Remel™ BactiSwab™ Wire Shaft Amies Clear | Wire Shaft Amies Clear is supplied with a mini-tip swab suitable for ear, nose, throat, eye, male urethral and pediatric specimen collection | |
Amies Agar Gel Transport Swab | Transportation of throat, vaginal, wound and skin swabs. Amies Agar Gel Transport Swabs come with soft rayon tips, which are inert and non-toxic to microorganisms | |
Detectand isolate | ||
| Remel™ Columbia Blood Agar w/3% Sheep Blood | General-purpose medium for cultivation, isolation and hemolytic determination of microorganisms | |
Columbia CNA Agar with Sheep Blood Medium | Identify staphylococci and streptococci | |
| Remel™ Blood Agar w/Gentamicin | Selective isolation of Streptococcus pneumoniae | |
Remel™ Chocolate Agar w/Bacitracin | Isolation of Haemophilus from respiratory specimens containing mixed flora | |
| Remel™ Schaedler Agar w/Blood, Hemin, Vitamin K | Isolation of anaerobic bacteria from clinical specimens | |
TV5112 TV5122C | Loewenstein-Jensen Medium | Isolation of Mycobacteria from clinical specimens |
| MacConkey Agar Medium | Detect and enumerate coliform organisms, including E. coli, while isolating and detecting Salmonella and Shigella specimens | |
Spectra™ MRSA Medium | Chromogenic screening plate for Methicillin Resistant Staphylococcus aureus (MRSA) | |
VersaTREK™ REDOX™ Media | Aerobic media | |
VersaTREK™ REDOX™ Media | Anaerobic media | |
Signal™ Blood Culture System | Detect the growth of aerobic, anaerobic and micro-aerophilic organisms from blood samples | |
Identify | ||
Remel™ BactiDrop™ PYR | Presumptive identification of group A streptococci and enterococci | |
Oxoid™ O.B.I.S. PYR | Detection of PYRase activity in streptococcal microorganisms and Citrobacter sp. from culture | |
DrySpot™ Pneumo Latex Agglutination Test | Detection of capsular antigen from Streptococcus pneumoniae to provide rapid identification of Strep. pneumoniae isolated from culture plates and blood culture | |
Wellcogen™ Streptococcus pneumoniae Rapid Latex Agglutination Test, Wellcogen S. pneumoniae Kit | Detection of capsular antigen from Streptococcus pneumoniae (Pneumococcus) | |
| Remel™ PathoDxtra™ Strep Grouping Kit | For identification of Group A, B, C, D, F and G streptococcus | |
Staphaurex™ Plus Latex Agglutination Test | Identify staphylococci which possess clumping factor, protein A, and/or surface antigens, including those characteristic of Methicillin Resistant Staphylococcus aureus (MRSA) and Methicillin Sensitive Staphylococcus aureus (MSSA) strains | |
Oxoid™ PBP2' Latex Agglutination Test Kit | Detection of PBP2' as an aid in identifying methicillin resistance in both Staphylococcus aureus (MRSA) and coagulase-negative Staphylococci. | |
| Remel™ Gram Stain Kit, 4 x 250 mL bottles | Differentiate Gram-positive from Gram-negative microorganisms | |
R8311006 | RapID™ ONE System | Identify medically important Enterobacteriaceae and other selected oxidase-negative, Gram-negative bacilli isolated from human clinical specimens |
Sensititre™ Gram Negative GNID ID Plate | Obtain presumptive identification of Gram negative organisms in just five hours, or obtain species level identification with overnight incubation | |
Sensititre™ Gram Negative GPID ID Plate | Obtain species-level identification of Gram-positive organisms with overnight incubation | |
Susceptibility Test | ||
Test multiple antibiotics simultaneously, on a plate format which can be run either manually, or using scalable automated instrumentation options to meet laboratory throughput | ||
| Sensititre™ Gram Negative AST Plate | Perform susceptibility testing of multidrug-resistant, Gram-Negative isolates against a comprehensive range of second-line antimicrobials on a single platform | |
| Sensititre™ Streptococcus FDANDSF AST Plate | Perform antimicrobial susceptibility testing (AST) of Streptococcus isolates | |
Sensititre™ Streptococcus STP6F AST Plate | Perform antimicrobial susceptibility testing (AST) of Streptococcus isolates | |
| Sensititre™ Haemophilus and Streptococcus HPB1 AST Plate | Perform antimicrobial susceptibility testing (AST) of Haemophilus and Streptococcus | |
| Sensititre™ Gram Negative GN7F AST Plate | Perform antimicrobial susceptibility testing (AST) of Gram-negative isolates on a single plate which includes antimicrobials ceftazidime/avibactam and ceftolozane/tazobactam | |
Sensititre™ Gram Positive AST Plate | Perform antimicrobial susceptibility testing (AST) of non-fastidious Gram positive isolates | |
Latest disc formats to support testing against multiple drug resistant bacteria | ||
CT1948B | Oxoid™ Ceftazidime/Avibactam Antimicrobial Susceptibility Disks | Ceftazidime/Avibactam is indicated for the treatment of complicated urinary tract infections, including pyelonephritis, in patients 18 years or older. In combination with metronidazole, it is also indicated for the treatment of complicated intra-abdominal infections. (CLSI or EUCAST compliant) |
Oxoid™ Meropenem/Vaborbactam MEV30 Antimicrobial Susceptibility Discs | Perform antimicrobial susceptibility testing (AST) of carbapenem-resistant - Enterobacteriaceae (CRE). (CLSI or EUCAST compliant) | |
* Research use only
Every laboratory requires Quality Control (QC) organisms to validate test results against stabilized, viable microorganisms.
Thermo Scientific™ Culti-Loops™ are ready-to-use QC organisms, for use at each stage of the workflow.
Organism | Product code | Collection & transport | Detect & isolate | Identify | Susceptibility test |
Campylobacter jejuni subsp. jejuni ATCC® 33291™ | ✓ | ||||
Candida albicans ATCC® 10231™ | R4601503 |
| ✓ |
| |
Citrobacter freundii ATCC® 8090™ |
| ✓ | |||
Enterococcus faecalis ATCC® 29212™ |
| ✓ | ✓ | ✓ | |
Enterococcus faecalis ATCC® 51299™ |
|
|
| ✓ | |
Escherichia coli ATCC® 25922™ |
| ✓ |
| ✓ | |
Haemophilus influenzae ATCC® 49766™ |
|
|
| ✓ | |
Haemophilus influenzae Type b ATCC® 10211™ | R4603810 | ✓ | ✓ |
| |
Neisseria gonorrhoeae ATCC® 43069™ | ✓ | ||||
Neisseria gonorrhoeae ATCC® 49226™ |
| ✓ | |||
Proteus hauseri ATCC® 13315™ |
| ✓ | |||
Proteus mirabilis ATCC® 12453™ |
| ✓ | |||
Proteus vulgaris ATCC® 8427™ |
| ✓ | |||
Pseudomonas aeruginosa ATCC® 27853™ |
| ✓ |
| ✓ | |
Salmonella enterca subsp. enterca serovar Typhimurium ATCC® 14028™ |
|
| ✓ |
| |
Salmonella enterica subsp. enterica serovarEnteritidis ATCC® 13076™ |
|
| ✓ | ||
Shigella flexneri serovar 2b group B ATCC® 12022™ | ✓ | ||||
Staphylococcus aureus subsp. aureus ATCC® 25923™ |
| ✓ |
| ✓ | |
Staphylococcus aureus subsp. aureus ATCC® 29213™ |
|
|
| ✓ | |
Staphylococcus epidermidis ATCC® 12228™ |
| ✓ | |||
Streptococcus agalactiae group B ATCC® 12386™ |
|
| ✓ | ||
Streptococcus pneumoniae ATCC® 49619™ |
|
|
| ✓ | |
Streptococcus pneumoniae ATCC® 6305™ |
| ✓ | |||
Streptococcus pyogenes ATCC® 19615™ | ✓ | ✓ | ✓ |
| |
Streptococcus sanguinis Type 1 ATCC® 10556™ |
| ✓ |
|
|
Need support identifying your product mix?
Hospital Acquired Pneumonia (HAP) and Ventilator Associated Pneumonia (VAP)
While data is still emerging, reports have suggested that 15% of hospitalized coronavirus patients developed a secondary bacterial infection, the definition of which is: clinical symptoms or signs of pneumonia or bacteraemia with positive culture1.
Among patients who died from coronavirus, 16% of patients had secondary infections2.
Sample collection, transport, identification and accurate treatment is vital to reducing patients' time in hospital and ultimately saving lives.
Be sure of your influenza identification this season
Redeem the offer on: Thermo Scientific™ Xpect™ Flu A&B Kits
Buy four and get one test kit at no additional charge.
Download the Thermo Scientific Coronavirus Care SmartNotes
The ATCC Licensed Derivative Emblem, the ATCC Licensed Derivative word mark and the ATCC catalog marks are trademarks of ATCC. Remel Inc. is licensed to use these trademarks and to sell products derived from ATCC® cultures. The identity, purity, and authenticity of the Licensed Products are exclusively the responsibility of Remel Inc., and not ATCC.
References
1. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 11[Online ahead of print].
2. Ruan, Q., Yang, K., Wang, W. et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med (2020). https://doi.org/10.1007/s00134-020-05991-x